Goƫrtz, Yvonne M. J.
Braamse, Annemarie M. J.
Spruit, Martijn A.
Janssen, Daisy J. A.
Ebadi, Zjala
Van Herck, Maarten
Burtin, Chris
Peters, Jeannette B.
Sprangers, Mirjam A. G.
Lamers, Femke
Twisk, Jos W. R.
Thong, Melissa S. Y.
Vercoulen, Jan H.
Geerlings, Suzanne E.
Vaes, Anouk W.
Beijers, Rosanne J. H. C. G.
van Beers, Martijn
Schols, Annemie M. W. J.
Rosmalen, Judith G. M.
Knoop, Hans
Funding for this research was provided by:
Longfonds (4.1.16.085)
Article History
Received: 7 May 2021
Accepted: 7 October 2021
First Online: 25 October 2021
Competing interests
: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf. Y.M.J.G., A.M.J.B., Z.E., M.V.H., C.B., J.B.P., M.A.G.S., F.L., J.W.R.T., M.S.Y.T., J.H.V., S.E.G., A.W.V., R.J.H.C.G.B., M.B., A.M.W.J.S., J.G.M.R. and H.K. have nothing to disclose. D.A.J. reports personal fees from Novartis, personal fees from Boehringer Ingelheim, personal fees from AstraZeneca, outside the submitted work. M.A.S. reports grants from Lung Foundation Netherlands, grants from Stichting Astma Bestrijding, grants and personal fees from Boehringer Ingelheim, and grants and personal fees from AstraZeneca, outside the submitted work.